ce CONTINUING EDUCATION azathioprine Moved from Table 2- to Table 1
Pertuzumab
NIOSH reviewed data from studies provided by the manufacturer and de- termined it is unlikely that pertuzumab poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. NIOSH reviewed data from studies provided by the manufacturer and determined it is unlikely that risperidone poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer con- sidered a hazardous drug by NIOSH. NIOSH deleted telavancin from the list based on data from reproductive studies conducted by the manufactur- er regarding its lack of reproductive toxicity.
cabergoline
Moved from Table 3- to Table 2 Moved from Table 2- to Table 1 Moved from Table 2- to Table 1 Moved from Table 3- to Table 2 Moved from Table 3- to Table 2 Moved from Table 3 to Table 2 Moved from Table 2 to Table 1 Moved from Table 3 to Table 2 Moved from Table 2 to Table 1 Moved from Table 2 to Table 1 Moved from Table 3 to Table 2 Moved from Table 3 to Table 2 Moved from Table 2 to Table Moved from Table 1 to Table 2 Moved from Table 1 to Table 2 Moved from Table 1 to Table 2 Moved from Table 3 to Table 2 Moved from Table 2 to Table 1 Moved from Table 3 to Table 2 Moved from Table 3 to Table 2 Moved from Table 3 to Table 2 Moved from Table 3 to Table 2 Moved from Table 3 to Table 2 Moved from Table 2 to Table 1 Moved from Table 3 to Table 2 Moved from Table 3 to Table 2 Moved from Table 3 to Table 2
chloramphenicol
cidofovir
clomiphene clonazepam
Risperidone
colchicine
cyclosporine dutasteride
estrogen-progesterone combinations estrogens, conjugated
Telavancin
finasteride fluconazole ganciclovir letrozole leuprolide megestrol misoprostol
Prior to the release of the NIOSH List of Drugs of Hazardous Drugs in Healthcare Settings, 2024 there were 5 tables of Hazardous Drug Information. The list released in 2024 was reduced from five tables down to two tables. Refer to Table 5 of some of the drugs which were move from which table to their current table.
mycophenolate mofetil
oxytocin
paroxetine
ribavirin
Table 5 Drugs Moved to a Different Table (Excerpts)
temazepam testosterone thalidomide
Drug
Notation
valproate/valproic acid
abiraterone
Moved from Table 1- to Table 2 Moved from Table 3- to Table 2 Moved from Table 1- to Table 2
warfarin
acitretin
ziprasidone
anastrozole
CPhT CONNECT www.cphtconnect.com
45
Made with FlippingBook - PDF hosting